G Cheymol

1.9k total citations
97 papers, 1.4k citations indexed

About

G Cheymol is a scholar working on Cardiology and Cardiovascular Medicine, Analytical Chemistry and Pharmacology. According to data from OpenAlex, G Cheymol has authored 97 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 19 papers in Analytical Chemistry and 18 papers in Pharmacology. Recurrent topics in G Cheymol's work include Cardiac electrophysiology and arrhythmias (19 papers), Analytical Methods in Pharmaceuticals (19 papers) and Cardiac Arrhythmias and Treatments (11 papers). G Cheymol is often cited by papers focused on Cardiac electrophysiology and arrhythmias (19 papers), Analytical Methods in Pharmaceuticals (19 papers) and Cardiac Arrhythmias and Treatments (11 papers). G Cheymol collaborates with scholars based in France, Belgium and New Zealand. G Cheymol's co-authors include J.‐M. POIRIER, Patrice Jaillon, Jean‐Marie Poirier, J Weissenburger, J Weissenburger, Martine Lebot, M Biour, Brigitte Lecocq, J. Dry and Pierre Lainée and has published in prestigious journals such as Journal of the American College of Cardiology, Hepatology and The American Journal of Cardiology.

In The Last Decade

G Cheymol

89 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Cheymol France 19 491 295 248 177 155 97 1.4k
A. W. Kelman United Kingdom 21 334 0.7× 255 0.9× 132 0.5× 321 1.8× 121 0.8× 73 1.6k
Renato L. Galeazzi Switzerland 16 177 0.4× 371 1.3× 280 1.1× 188 1.1× 138 0.9× 45 1.6k
David Lalka United States 23 267 0.5× 364 1.2× 339 1.4× 230 1.3× 123 0.8× 71 1.8k
Sylvia M. Wallace Canada 21 252 0.5× 272 0.9× 177 0.7× 194 1.1× 80 0.5× 44 1.6k
PA Routledge United Kingdom 28 788 1.6× 298 1.0× 308 1.2× 374 2.1× 157 1.0× 107 2.4k
Marc G. Bogaert Belgium 21 191 0.4× 282 1.0× 243 1.0× 183 1.0× 132 0.9× 85 1.5k
Diane K. Jorkasky United States 27 425 0.9× 144 0.5× 341 1.4× 353 2.0× 138 0.9× 68 1.7k
Jens P. Kampmann Denmark 21 282 0.6× 304 1.0× 94 0.4× 145 0.8× 113 0.7× 71 1.5k
John A. Opsahl United States 17 457 0.9× 189 0.6× 200 0.8× 197 1.1× 89 0.6× 48 1.1k
Mario L. Rocci United States 24 197 0.4× 360 1.2× 326 1.3× 136 0.8× 178 1.1× 73 2.1k

Countries citing papers authored by G Cheymol

Since Specialization
Citations

This map shows the geographic impact of G Cheymol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Cheymol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Cheymol more than expected).

Fields of papers citing papers by G Cheymol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Cheymol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Cheymol. The network helps show where G Cheymol may publish in the future.

Co-authorship network of co-authors of G Cheymol

This figure shows the co-authorship network connecting the top 25 collaborators of G Cheymol. A scholar is included among the top collaborators of G Cheymol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Cheymol. G Cheymol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weissenburger, J, Michel Noyer, G Cheymol, & Patrice Jaillon. (1999). Electrophysiological effects of cetirizine, astemizole and d‐sotalol in a canine model of long QT syndrome. Clinical & Experimental Allergy. 29(S3). 190–196. 20 indexed citations
2.
Isnard, Françoise, et al.. (1997). Plasma Itraconazole Concentrations in Patients With Neutropenia. Therapeutic Drug Monitoring. 19(5). 525–529. 15 indexed citations
3.
Weissenburger, J, et al.. (1995). Proarrhythmic effects of a quinidine analog in dogs with chronic A‐V block. Fundamental and Clinical Pharmacology. 9(3). 240–247. 11 indexed citations
4.
Poirier, Jean‐Marie, et al.. (1994). Determination of Itraconazole and Its Active Metabolite in Plasma by Column Liquid Chromatography. Therapeutic Drug Monitoring. 16(6). 596–601. 31 indexed citations
5.
Weissenburger, J, et al.. (1993). Reproducibility of the model of induced ventricular tachycardia in conscious dogs with infarction. Journal of Pharmacological and Toxicological Methods. 29(1). 45–57. 1 indexed citations
6.
Poirier, Jean‐Marie, Martine Lebot, & G Cheymol. (1992). Rapid and Sensitive Liquid Chromatographic Assay of Mefenamic Acid in Plasma. Therapeutic Drug Monitoring. 14(4). 322–326. 7 indexed citations
7.
Jeunne, Claire Le, et al.. (1991). Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers. European Journal of Clinical Pharmacology. 41(2). 171–174. 19 indexed citations
8.
Weissenburger, J, et al.. (1990). Comparison of the Cardiac Electrophysiological Effects of Flecainide and Hydroquinidine in Anesthetized Dog. Journal of Cardiovascular Pharmacology. 15(1). 50–56. 4 indexed citations
9.
Weissenburger, J, et al.. (1990). Torsade de pointes late after I.V. Quinidine in conscious dogs with AV-block. Comparison with acute effects. Journal of the American College of Cardiology. 15(2). A38–A38. 4 indexed citations
10.
Cheymol, G. (1990). [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].. PubMed. 174(7). 959–67; discussion 967. 5 indexed citations
11.
POIRIER, J.‐M., et al.. (1990). The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers. European Journal of Clinical Pharmacology. 38(6). 579–582. 30 indexed citations
12.
Rames, Alexis, Brigitte Lecocq, Jean‐Didier Grangé, et al.. (1990). Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients. Clinical Pharmacology & Therapeutics. 47(3). 354–359. 35 indexed citations
13.
Biour, M, R. Poupon, Jean‐Daniel Grange, et al.. (1988). Hépatotoxicité des médicaments. Mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables.. Gastroentérologie Clinique et Biologique. 12(1). 64–88. 12 indexed citations
14.
Cheymol, G. (1988). DRUG PHARMACOKINETICS IN THE OBESE*. Fundamental and Clinical Pharmacology. 2(3). 239–256. 40 indexed citations
15.
POIRIER, J.‐M., et al.. (1988). Amiodarone pharmacokinetics in coronary patients: Differences between acute and one-month chronic dosing. European Journal of Drug Metabolism and Pharmacokinetics. 13(1). 67–72. 5 indexed citations
16.
Biour, M, et al.. (1986). [A microcomputer databank of hepatotoxic drugs].. PubMed. 40(5). 329–32. 1 indexed citations
17.
Jaillon, Patrice, Jean‐Marie Poirier, G Cheymol, et al.. (1985). Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: Relationship to plasma concentrations—a French multicenter trial. American Heart Journal. 110(3). 575–581. 13 indexed citations
18.
Cheymol, G, et al.. (1981). [Pharmacokinetic study of sotalol administered intravenously to healthy men. Application of high performance liquid chromatography (author's transl)].. PubMed. 36(4). 465–71. 6 indexed citations
19.
Cheymol, G, et al.. (1978). [Study in man of butobarbital pharmacokinetics, under polygraphic monitoring].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(3). 363–72. 1 indexed citations
20.
Cheymol, G, et al.. (1977). Cardiovascular and antiarrhythmic effects of fendiline compared to prenylamine in the dog.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(10). 1954–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. W. Kelman Breakdown of academic impact, for papers by Renato L. Galeazzi Breakdown of academic impact, for papers by David Lalka Breakdown of academic impact, for papers by Sylvia M. Wallace Breakdown of academic impact, for papers by PA Routledge Breakdown of academic impact, for papers by Marc G. Bogaert Breakdown of academic impact, for papers by Diane K. Jorkasky Breakdown of academic impact, for papers by Jens P. Kampmann Breakdown of academic impact, for papers by John A. Opsahl Breakdown of academic impact, for papers by Mario L. Rocci
Rankless by CCL
2026